Introduction {#s0005}
============

KEY TEACHING POINTS•LAmbre is a newly designed 2-disc closure device for transcatheter left atrial appendage (LAA) closure.•Although the procedure of transcatheter LAA closure has a higher rate of air thromboembolism than routine interventional procedures like percutaneous coronary intervention or closure of atrial septal defect/ventricular septal defect, this is the first reported that was limited to the LAA with excellent images of both transesophageal echocardiogram and fluoroscopy.•The iatrogenic air embolus of this case was due to the faulty use of a pressure infusion bag with the 500-mm bag of saline, which was wrapped by the former. A small but practical tip for prevention of a similar error is to use the pressure infusion bag with 1000-mm bag of saline.•The presence of embolus in the LAA is one of the contraindications for transcatheter LAA closure using WATCHMAN, but not the LAmbre.

Left atrial appendage (LAA) closure is an alternative therapy for the patients with non-valvular atrial fibrillation. However, several complications were reported in the procedure. We reported a classic image of air emboli formed unexpectedly during the procedure of transcatheter LAA closure, which was closed using a LAmbre occulder.

Case report {#s0010}
===========

An 80-year-old Chinese woman with permanent atrial fibrillation was referred for transcatheter left atrial appendage (LAA) closure using LAmbre (Lifetech Scientific Co, Shenzhen, China), a new-generation double-disc closure device.[@bib1], [@bib2] The patient had a history of hypertension and 1 event of ischemic stroke, with a CHADS~2~ score of 4. She was reluctant to receive warfarin because of the inconvenience of medical surveillance. Before the procedure, a transesophageal echocardiogram (TEE) revealed a windsock-like LAA[@bib3], [@bib4] with no presence of thrombi or sludge ([Figure 1A](#f0005){ref-type="fig"}; [Video 1](#s0025){ref-type="sec"}, available online). The procedure was conducted under general anesthesia. LAA was measured through multiview fluoroscopy ([Figure 1B](#f0005){ref-type="fig"}; [Video 2](#s0025){ref-type="sec"}, available online) and monitoring TEE to select the appropriate size of the closure, which would be used to seal the orifice of the LAA subsequently. Unexpectedly, a tube of air was accidentally injected into the LAA from the delivery sheath because it was not noticed that the empty 500-mm bag of saline was wrapped by the pressure infusion bag ([Supplementary Figure 1](#s0025){ref-type="sec"}). Very quickly, thick air thrombi formed in the bottom of the LAA ([Figure 1C](#f0005){ref-type="fig"} and [D](#f0005){ref-type="fig"}; [Appendix](#s0025){ref-type="sec"}, [Appendix](#s0025){ref-type="sec"}, available online). Then, a quick implantation of LAmbre was conducted. The fixed disc was anchored in the landing zone ([Figure 2A](#f0010){ref-type="fig"} and [B](#f0010){ref-type="fig"}; [Appendix](#s0025){ref-type="sec"}, [Appendix](#s0025){ref-type="sec"}, available online) prior to the deployment of the sealing disc ([Video 7](#s0025){ref-type="sec"}, available online). After the unsheathing of the LAmbre implanter with the delivery sheath, a fluoroscopy showed good location and sealing effect ([Figure 2C](#f0010){ref-type="fig"}; [Video 8](#s0025){ref-type="sec"}, available online). TEE showed no residual shunt around the device ([Figure 2D](#f0010){ref-type="fig"}; [Video 9](#s0025){ref-type="sec"}, available online). There were no electrocardiogram changes or symptoms or signs of stroke during the procedure. The patient underwent an uneventful recovery and was discharged 3 days after the procedure. Three-month routine TEE showed complete sealing of the LAA ([Figure 2E](#f0010){ref-type="fig"}; [Video 10](#s0025){ref-type="sec"}, available online). At present, there has been no recurrence of stroke or any severe adverse event in this patient after 7-month follow-up.

Appendix. Supplementary data {#s0025}
============================

**Video 1** A preprocedural transesophageal echocardiogram indicated a windsock-like left atrial appendage with no thrombi, sludge, or spontaneous echocardiographic contrast.

**Video 2** Selective angiogram of left atrial appendage (LAA) was used to measure the orifice of the LAA, also indicating there was no filling defect.

**Video 3** Monitoring transesophageal echocardiogram showed thick air thrombi formed in the bottom of the left atrial appendage (LAA) during the procedure of transcatheter LAA closure.

**Video 4** Fluoroscopy also showed a large filling defect in the bottom of the left atrial appendage (LAA) during the procedure of transcatheter LAA closure.

**Video 5** During the procedure of transcatheter left atrial appendage closure, the fixed disc was anchored in the landing zone first, under the guidance of angiography.

**Video 6** During the procedure of transcatheter left atrial appendage (LAA) closure, monitoring transesophageal echocardiogram showed the deployment of the fixed disc of the LAmbre device, which was anchored in the landing zone, close to the orifice of the LAA.

**Video 7** After the deployment of the fixed disc, the sealing disc of the LAmbre closure was released to seal the left atrial appendage orifice.

**Video 8** After the unlocking of the LAmbre implanter with the delivery sheath, an angiogram showed good location and sealing effect. LAA = left atrial appendage.

**Video 9** After the unlocking of the LAmbre implanter with the delivery sheath, monitoring transesophageal echocardiogram (TEE) showed no residual shunt around the device. LAA = left atrial appendage.

**Video 10** After the procedure of transcatheter left atrial appendage (LAA) closure, 3-month routine transesophageal echocardiogram (TEE) showed complete sealing of LAA with no residual flow.

Supplementary Figure 1The pressure infusion bag and the 500-mm bag of saline that were used in this case. The saline was almost wrapped by the pressure infusion bag.
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![Air thrombi formed in the bottle of left atrial appendage (LAA) during the procedure of transcatheter LAA closure. **A:** A preprocedural transesophageal echocardiogram indicated a windsock-like LAA (*white arrow*) with no thrombi, sludge, or spontaneous echocardiographic contrast. **B:** The first fluoroscopy of the LAA showed no thrombus in the LAA. **C:** Thick air thrombi (*black arrow*) formed in the bottom of the LAA during the transcatheter LAA closure. **D:** The subsequent LAA radiogram also showed the presence of a large filling defect in the bottom of the LAA. LA = left atrium.](gr1){#f0005}

![Transcatheter left atrial appendage (LAA) closure with LAmbre was conducted to seal the LAA and the thrombi. **A:** The fixed disc (*white arrow*) of the LAmbre device was quickly released and anchored in the landing zone. **B:** The monitoring transesophageal echocardiogram (TEE) revealed good location of the fixed disc. **C:** A transcatheter angiogram showed no obvious residual flow around the device after the total deployment of the LAmbre implanter. **D:** The monitoring TEE revealed good performance of the LAmbre device (*white arrow*). **E:** Three-month follow-up TEE showed good sealing of LAA closure and no residual shunt around the device. LA = left atrium.](gr2){#f0010}
